Pharmacy Times®
Specialty Pharmacy Times
  • Sunscreen Use During Childhood Reduces Melanoma Risk in Adulthood
  • Biosimilar Development Still Fraught with Challenges for Manufacturers
  • Researchers Find Link Between High Cholesterol and Breast Cancer
  • HIV Diagnosis Rate in US on Decline Over Past Decade
  • New Prostate Cancer Blood Test Decreases Need for Biopsy
  • Breast Cancer Therapeutics Market Projected to Grow $4 Billion by 2020
NASP and SPAARx Merge to Create a Unified Specialty Pharmacy Association
NASP/SPAARx merger creates one, unified voice representing the fastest growing segments in the pharmacy and health care industries.
FDA Accepts First Application in US for Biosimilar
Davy James, Associate Editor
Biologics License Application filed for filgrastim by Sandoz.
HIV in the Crosshairs: Researchers’ Tool Targets and Removes Virus from Cell Genome
Eileen Oldfield, Associate Editor
Temple University researchers’ tool requires further investigation, targets virus cells specifically.
Entyvio by Takeda Pharmaceuticals America, Inc
Michael R. Page, PharmD, RPh
The FDA has approved Entyvio (vedolizumab), an integrin-receptor antagonist for treatment of ulcerative colitis and Crohn’s disease in adult patients.
A New Biweekly Dosing Option for CSL Behring’s Hizentra
Michael R. Page, PharmD, RPh
The FDA has approved a new dosing regimen for Hizentra, a subcutaneously administered immunoglobulin. The new dosing regimen allows Hizentra to be administered once every 2 weeks to treat patients with primary immunodeficiency.
Featured Video
Emerging Trends in Pharmacy Benefit Management
Davy James, Associate Editor
Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses key trends in pharmacy benefit management that specialty pharmacies need to be aware of.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 5
Number: 3
Conference Calendar
â—„        July 2014        â–ş
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.